Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2019
Significance of <i>BRCA2</i> and <i>RB1</i> Co-loss in Aggressive Prostate Cancer Progression
Goutam Chakraborty, Joshua Armenia, Ying Z Mazzu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2020
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response
Ben Sidders, Pei Zhang, Kelly Goodwin, et al.
Cancer Research Communications
|
June 1, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE Study
Rahul R Aggarwal, Antoine Italiano, Susan M Domchek, et al.
The Journal of Clinical Investigation
|
June 5, 2018
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D
Kazumasa Komura, Yuki Yoshikawa, Teppei Shimamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
Ying Z Mazzu, Joshua Armenia, Goutam Chakraborty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2016
Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer
Martin G Dalin, Alexis Desrichard, Nora Katabi, et al.
Nature Genetics
|
July 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancers
Craig M Bielski, Ahmet Zehir, Alexander V Penson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2018
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
European Urology
|
October 7, 2018
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
Eugene J Pietzak, Emily C Zabor, Aditya Bagrodia, et al.
JCO Precision Oncology
|
October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
David R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2019
Significance of <i>BRCA2</i> and <i>RB1</i> Co-loss in Aggressive Prostate Cancer Progression
Goutam Chakraborty, Joshua Armenia, Ying Z Mazzu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2020
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response
Ben Sidders, Pei Zhang, Kelly Goodwin, et al.
Cancer Research Communications
|
June 1, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE Study
Rahul R Aggarwal, Antoine Italiano, Susan M Domchek, et al.
The Journal of Clinical Investigation
|
June 5, 2018
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D
Kazumasa Komura, Yuki Yoshikawa, Teppei Shimamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
Ying Z Mazzu, Joshua Armenia, Goutam Chakraborty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2016
Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer
Martin G Dalin, Alexis Desrichard, Nora Katabi, et al.
Nature Genetics
|
July 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancers
Craig M Bielski, Ahmet Zehir, Alexander V Penson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2018
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
European Urology
|
October 7, 2018
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
Eugene J Pietzak, Emily C Zabor, Aditya Bagrodia, et al.
JCO Precision Oncology
|
October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
David R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Page
of 4